Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8322 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8322 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8239 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8108 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8052 |
Intermediate Similarity |
NPD1653 |
Approved |
0.805 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8042 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7972 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7929 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7929 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7927 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7925 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7925 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7925 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7847 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7843 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7736 |
Intermediate Similarity |
NPD37 |
Approved |
0.773 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7725 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7714 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7677 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7619 |
Intermediate Similarity |
NPD7472 |
Approved |
0.753 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7529 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.75 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7485 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7469 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7469 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7467 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7467 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7431 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7427 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7407 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7403 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD228 |
Approved |
0.7384 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7378 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7322 |
Intermediate Similarity |
NPD7680 |
Approved |
0.732 |
Intermediate Similarity |
NPD4538 |
Approved |
0.732 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7305 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7292 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7292 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7278 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7256 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7237 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7215 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7214 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7211 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7198 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7179 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7153 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7122 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7122 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7105 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7095 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7095 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7089 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7066 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7063 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7052 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7048 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7047 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7044 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7044 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7027 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD4663 |
Approved |
0.702 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6983 |
Remote Similarity |
NPD7243 |
Clinical (unspecified phase) |
0.6983 |
Remote Similarity |
NPD7906 |
Approved |
0.6981 |
Remote Similarity |
NPD3060 |
Approved |
0.6977 |
Remote Similarity |
NPD2489 |
Approved |
0.6977 |
Remote Similarity |
NPD27 |
Approved |
0.6975 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6962 |
Remote Similarity |
NPD5762 |
Approved |
0.6962 |
Remote Similarity |
NPD5763 |
Approved |
0.6954 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6954 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6949 |
Remote Similarity |
NPD7312 |
Approved |
0.6949 |
Remote Similarity |
NPD7311 |
Approved |
0.6949 |
Remote Similarity |
NPD8313 |
Approved |
0.6949 |
Remote Similarity |
NPD4577 |
Approved |
0.6949 |
Remote Similarity |
NPD7310 |
Approved |
0.6949 |
Remote Similarity |
NPD7313 |
Approved |
0.6949 |
Remote Similarity |
NPD8312 |
Approved |
0.6949 |
Remote Similarity |
NPD4578 |
Approved |
0.6948 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD5772 |
Approved |
0.6946 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD5773 |
Approved |
0.6943 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6923 |
Remote Similarity |
NPD6653 |
Approved |
0.6919 |
Remote Similarity |
NPD2970 |
Approved |
0.6919 |
Remote Similarity |
NPD2969 |
Approved |
0.6914 |
Remote Similarity |
NPD1511 |
Approved |
0.691 |
Remote Similarity |
NPD7309 |
Approved |
0.6909 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6906 |
Remote Similarity |
NPD968 |
Approved |
0.6905 |
Remote Similarity |
NPD2560 |
Approved |
0.6905 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD2563 |
Approved |
0.6903 |
Remote Similarity |
NPD4140 |
Approved |
0.6901 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6899 |
Remote Similarity |
NPD2161 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6894 |
Remote Similarity |
NPD2677 |
Approved |
0.6886 |
Remote Similarity |
NPD3382 |
Approved |
0.6886 |
Remote Similarity |
NPD3384 |
Approved |
0.6886 |
Remote Similarity |
NPD3383 |
Approved |
0.6883 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6875 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD4162 |
Approved |
0.6871 |
Remote Similarity |
NPD4123 |
Phase 3 |
0.6867 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.686 |
Remote Similarity |
NPD6071 |
Discontinued |
0.686 |
Remote Similarity |
NPD3051 |
Approved |
0.6859 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6857 |
Remote Similarity |
NPD290 |
Approved |
0.6848 |
Remote Similarity |
NPD4210 |
Discontinued |
0.6848 |
Remote Similarity |
NPD3687 |
Approved |
0.6848 |
Remote Similarity |
NPD3686 |
Approved |
0.6842 |
Remote Similarity |
NPD5494 |
Approved |
0.6839 |
Remote Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD4535 |
Phase 3 |
0.6829 |
Remote Similarity |
NPD1512 |
Approved |
0.6829 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD5604 |
Discontinued |
0.6821 |
Remote Similarity |
NPD6696 |
Suspended |
0.6815 |
Remote Similarity |
NPD6353 |
Approved |
0.6813 |
Remote Similarity |
NPD2424 |
Discontinued |
0.68 |
Remote Similarity |
NPD2231 |
Phase 2 |
0.68 |
Remote Similarity |
NPD2235 |
Phase 2 |
0.6796 |
Remote Similarity |
NPD6842 |
Approved |
0.6796 |
Remote Similarity |
NPD6841 |
Approved |
0.6796 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6795 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6795 |
Remote Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.679 |
Remote Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.6786 |
Remote Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.678 |
Remote Similarity |
NPD7007 |
Discovery |
0.6776 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6772 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.677 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6768 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6766 |
Remote Similarity |
NPD4678 |
Approved |
0.6766 |
Remote Similarity |
NPD4675 |
Approved |
0.6758 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6757 |
Remote Similarity |
NPD5582 |
Discontinued |
0.6755 |
Remote Similarity |
NPD6582 |
Phase 2 |
0.6755 |
Remote Similarity |
NPD5327 |
Phase 3 |
0.6755 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6755 |
Remote Similarity |
NPD3685 |
Discontinued |
0.6755 |
Remote Similarity |
NPD6583 |
Phase 3 |
0.6753 |
Remote Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.6752 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6752 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.675 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.675
|
Remote Similarity |
NPD6005 |
Phase 3 |